Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:05 PM EDT
124.89quote price arrow down-0.26 (-0.21%)
Volume
57,213
Close
125.15quote price arrow down-0.47 (-0.37%)
Volume
2,296,572
52 week range
115.03 - 376.65
Loading...
  • Open124.78
  • Day High127.64
  • Day Low122.93
  • Prev Close125.62
  • 52 Week High376.65
  • 52 Week High Date11/29/21
  • 52 Week Low115.03
  • 52 Week Low Date09/29/22

Key Stats

  • Market Cap48.959B
  • Shares Out391.20M
  • 10 Day Average Volume3.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.66
  • YTD % Change-50.72

KEY STATS

  • Open124.78
  • Day High127.64
  • Day Low122.93
  • Prev Close125.62
  • 52 Week High376.65
  • 52 Week High Date11/29/21
  • 52 Week Low115.03
  • 52 Week Low Date09/29/22
  • Market Cap48.959B
  • Shares Out391.20M
  • 10 Day Average Volume3.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.66
  • YTD % Change-50.72

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)3.82
  • Fwd P/E (NTM)8.09
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Friday's big stock calls on CNBC
VIDEO8:2708:27
Pro Picks: Watch all of Friday's big stock calls on CNBC

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
137.53+0.34+0.25%
BIIB
Biogen Inc
262.26+0.57+0.22%
REGN
Regeneron Pharmaceuticals Inc
731.86-13.82-1.85%
ILMN
Illumina Inc
212.72-5.80-2.65%
ALNY
Alnylam Pharmaceuticals Inc
202.37+1.35+0.67%